301 related articles for article (PubMed ID: 30284143)
1. AGXT2 and DDAH-1 genetic variants are highly correlated with serum ADMA and SDMA levels and with incidence of coronary artery disease in Egyptians.
Amir M; Hassanein SI; Abdel Rahman MF; Gad MZ
Mol Biol Rep; 2018 Dec; 45(6):2411-2419. PubMed ID: 30284143
[TBL] [Abstract][Full Text] [Related]
2. Genome-wide association study on dimethylarginines reveals novel AGXT2 variants associated with heart rate variability but not with overall mortality.
Seppälä I; Kleber ME; Lyytikäinen LP; Hernesniemi JA; Mäkelä KM; Oksala N; Laaksonen R; Pilz S; Tomaschitz A; Silbernagel G; Boehm BO; Grammer TB; Koskinen T; Juonala M; Hutri-Kähönen N; Alfthan G; Viikari JS; Kähonen M; Raitakari OT; März W; Meinitzer A; Lehtimäki T;
Eur Heart J; 2014 Feb; 35(8):524-31. PubMed ID: 24159190
[TBL] [Abstract][Full Text] [Related]
3. Alanine-glyoxylate aminotransferase 2 (AGXT2) polymorphisms have considerable impact on methylarginine and β-aminoisobutyrate metabolism in healthy volunteers.
Kittel A; Müller F; König J; Mieth M; Sticht H; Zolk O; Kralj A; Heinrich MR; Fromm MF; Maas R
PLoS One; 2014; 9(2):e88544. PubMed ID: 24586340
[TBL] [Abstract][Full Text] [Related]
4. Effects of AGXT2 variants on blood pressure and blood sugar among 750 older Japanese subjects recruited by the complete enumeration survey method.
Yoshino Y; Kumon H; Mori T; Yoshida T; Tachibana A; Shimizu H; Iga JI; Ueno SI
BMC Genomics; 2021 Apr; 22(1):287. PubMed ID: 33879046
[TBL] [Abstract][Full Text] [Related]
5. Genome-wide association study of L-arginine and dimethylarginines reveals novel metabolic pathway for symmetric dimethylarginine.
Lüneburg N; Lieb W; Zeller T; Chen MH; Maas R; Carter AM; Xanthakis V; Glazer NL; Schwedhelm E; Seshadri S; Ikram MA; Longstreth WT; Fornage M; König IR; Loley C; Ojeda FM; Schillert A; Wang TJ; Sticht H; Kittel A; König J; Benjamin EJ; Sullivan LM; Bernges I; Anderssohn M; Ziegler A; Gieger C; Illig T; Meisinger C; Wichmann HE; Wild PS; Schunkert H; Psaty BM; Wiggins KL; Heckbert SR; Smith N; Lackner K; Lunetta KL; Blankenberg S; Erdmann J; Munzel T; Grant PJ; Vasan RS; Böger RH
Circ Cardiovasc Genet; 2014 Dec; 7(6):864-72. PubMed ID: 25245031
[TBL] [Abstract][Full Text] [Related]
6. Genetic variations in the alanine-glyoxylate aminotransferase 2 (AGXT2) gene and dimethylarginines levels in rheumatoid arthritis.
Dimitroulas T; Hodson J; Panoulas VF; Sandoo A; Smith J; Kitas G
Amino Acids; 2017 Jun; 49(6):1133-1141. PubMed ID: 28357606
[TBL] [Abstract][Full Text] [Related]
7. Considerable impacts of AGXT2 V140I polymorphism on chronic heart failure in the Chinese population.
Hu XL; Zhou JP; Kuang DB; Qi H; Peng LM; Yang TL; Li X; Zhang W; Zhou HH; Chen XP
Atherosclerosis; 2016 Aug; 251():255-262. PubMed ID: 27423328
[TBL] [Abstract][Full Text] [Related]
8. Association of the AGXT2 V140I polymorphism with risk for coronary heart disease in a Chinese population.
Zhou JP; Bai YP; Hu XL; Kuang DB; Shi RZ; Xiong Y; Zhang W; Xia J; Chen BL; Yang TL; Chen XP
J Atheroscler Thromb; 2014; 21(10):1022-30. PubMed ID: 24834905
[TBL] [Abstract][Full Text] [Related]
9. ADMA, SDMA and L-arginine/ADMA ratio but not DDAH genetic polymorphisms are reliable predictors of diabetic nephropathy progression as identified by competing risk analysis.
Tanhäuserová V; Tomandl J; Pácal L; Klepárník M; Malúšková D; Bartáková V; Kuricová K; Rehořová J; Stěpánková S; Svojanovský J; Olšovský J; Bělobrádková J; Krusová D; Jurajda M; Mužík J; Pavlík T; Kaňková K
Kidney Blood Press Res; 2012; 36(1):200-8. PubMed ID: 23147199
[TBL] [Abstract][Full Text] [Related]
10. Genetic variation in the dimethylarginine dimethylaminohydrolase 1 gene (DDAH1) is related to asymmetric dimethylarginine (ADMA) levels, but not to endothelium-dependent vasodilation.
Lind L; Ingelsson E; Kumar J; Syvänen AC; Axelsson T; Teerlink T
Vasc Med; 2013 Aug; 18(4):192-9. PubMed ID: 23892448
[TBL] [Abstract][Full Text] [Related]
11. Age-related changes in ADMA-DDAH-NO pathway in rat liver subjected to partial ischemia followed by global reperfusion.
Trocha M; Merwid-Ląd A; Chlebda-Sieragowska E; Szuba A; Pieśniewska M; Fereniec-Gołębiewska L; Kwiatkowska J; Szeląg A; Sozański T
Exp Gerontol; 2014 Feb; 50():45-51. PubMed ID: 24269305
[TBL] [Abstract][Full Text] [Related]
12. Assessment of serum levels of asymmetric dimethylarginine, symmetric dimethylarginine and L-arginine in coronary artery disease.
Gad MZ; Hassanein SI; Abdel-Maksoud SM; Shaban GM; Abou-Aisha K; Elgabarty HA
Biomarkers; 2010 Dec; 15(8):746-52. PubMed ID: 20936901
[TBL] [Abstract][Full Text] [Related]
13. Role of alanine:glyoxylate aminotransferase 2 in metabolism of asymmetric dimethylarginine in the settings of asymmetric dimethylarginine overload and bilateral nephrectomy.
Rodionov RN; Martens-Lobenhoffer J; Brilloff S; Hohenstein B; Jarzebska N; Jabs N; Kittel A; Maas R; Weiss N; Bode-Böger SM
Nephrol Dial Transplant; 2014 Nov; 29(11):2035-42. PubMed ID: 25002409
[TBL] [Abstract][Full Text] [Related]
14. Human alanine-glyoxylate aminotransferase 2 lowers asymmetric dimethylarginine and protects from inhibition of nitric oxide production.
Rodionov RN; Murry DJ; Vaulman SF; Stevens JW; Lentz SR
J Biol Chem; 2010 Feb; 285(8):5385-91. PubMed ID: 20018850
[TBL] [Abstract][Full Text] [Related]
15. Associations of functional alanine-glyoxylate aminotransferase 2 gene variants with atrial fibrillation and ischemic stroke.
Seppälä I; Kleber ME; Bevan S; Lyytikäinen LP; Oksala N; Hernesniemi JA; Mäkelä KM; Rothwell PM; Sudlow C; Dichgans M; Mononen N; Vlachopoulou E; Sinisalo J; Delgado GE; Laaksonen R; Koskinen T; Scharnagl H; Kähönen M; Markus HS; März W; Lehtimäki T
Sci Rep; 2016 Mar; 6():23207. PubMed ID: 26984639
[TBL] [Abstract][Full Text] [Related]
16. Missense variants of the alanine: glyoxylate aminotransferase 2 gene correlated with carotid atherosclerosis in the Japanese population.
Yoshino Y; Kohara K; Abe M; Ochi S; Mori Y; Yamashita K; Igase M; Tabara Y; Mori T; Miki T; Ueno S
J Biol Regul Homeost Agents; 2014; 28(4):605-14. PubMed ID: 25620171
[TBL] [Abstract][Full Text] [Related]
17. The Second Life of Methylarginines as Cardiovascular Targets.
Jarzebska N; Mangoni AA; Martens-Lobenhoffer J; Bode-Böger SM; Rodionov RN
Int J Mol Sci; 2019 Sep; 20(18):. PubMed ID: 31533264
[TBL] [Abstract][Full Text] [Related]
18. Dimethylarginine Dimethylaminohydrolase 1 Polymorphisms and Venous Intimal Hyperplasia in Hemodialysis Patients.
Wu CC; Hsieh MY; Lee CK; Chuang SY; Chung MY; Lin CC
Am J Nephrol; 2019; 50(6):454-464. PubMed ID: 31639806
[TBL] [Abstract][Full Text] [Related]
19. AGXT2: An unnegligible aminotransferase in cardiovascular and urinary systems.
Hu XL; Li MP; Song PY; Tang J; Chen XP
J Mol Cell Cardiol; 2017 Dec; 113():33-38. PubMed ID: 28970090
[TBL] [Abstract][Full Text] [Related]
20. Missense variants of the alanine:glyoxylate aminotransferase 2 gene are not associated with Japanese schizophrenia patients.
Yoshino Y; Abe M; Numata S; Ochi S; Mori Y; Ishimaru T; Kinoshita M; Umehara H; Yamazaki K; Mori T; Ohmori T; Ueno S
Prog Neuropsychopharmacol Biol Psychiatry; 2014 Aug; 53():137-41. PubMed ID: 24727203
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
